162 related articles for article (PubMed ID: 7573713)
1. Japanese encephalitis virus-specific proliferative responses of human peripheral blood T lymphocytes.
Konishi E; Kurane I; Mason PW; Innis BL; Ennis FA
Am J Trop Med Hyg; 1995 Sep; 53(3):278-83. PubMed ID: 7573713
[TBL] [Abstract][Full Text] [Related]
2. Particulate vaccine candidate for Japanese encephalitis induces long-lasting virus-specific memory T lymphocytes in mice.
Konishi E; Win KS; Kurane I; Mason PW; Shope RE; Ennis FA
Vaccine; 1997 Feb; 15(3):281-6. PubMed ID: 9139487
[TBL] [Abstract][Full Text] [Related]
3. T-cell activation and induction of antibodies and memory T cells by immunization with inactivated Japanese encephalitis vaccine.
Aihara H; Takasaki T; Toyosaki-Maeda T; Suzuki R; Okuno Y; Kurane I
Viral Immunol; 2000; 13(2):179-86. PubMed ID: 10892998
[TBL] [Abstract][Full Text] [Related]
4. Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice.
Konishi E; Kurane I; Mason PW; Shope RE; Ennis FA
Virology; 1997 Jan; 227(2):353-60. PubMed ID: 9018134
[TBL] [Abstract][Full Text] [Related]
5. Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates.
Konishi E; Kurane I; Mason PW; Shope RE; Kanesa-Thasan N; Smucny JJ; Hoke CH; Ennis FA
Vaccine; 1998 May; 16(8):842-9. PubMed ID: 9627942
[TBL] [Abstract][Full Text] [Related]
6. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.
Konishi E; Yamaoka M; Kurane I; Mason PW
Virology; 2000 Mar; 268(1):49-55. PubMed ID: 10683326
[TBL] [Abstract][Full Text] [Related]
7. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
8. CD8
Kalia A; Agrawal M; Gupta N
Eur J Immunol; 2021 Feb; 51(2):368-379. PubMed ID: 32749679
[TBL] [Abstract][Full Text] [Related]
9. Construction and Immunogenicity of Recombinant Vaccinia Virus Vaccine Against Japanese Encephalitis and Chikungunya Viruses Infection in Mice.
Zhang Y; Han JC; Jing J; Liu H; Zhang H; Li ZH; Jin NY; Lu HJ
Vector Borne Zoonotic Dis; 2020 Oct; 20(10):788-796. PubMed ID: 32584657
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains.
Kurane I; Takasaki T
Vaccine; 2000 May; 18 Suppl 2():33-5. PubMed ID: 10821971
[TBL] [Abstract][Full Text] [Related]
11. Proliferative response of human peripheral blood mononuclear cells to Japanese encephalitis virus.
Desai A; Ravi V; Chandramuki A; Gourie-Devi M
Microbiol Immunol; 1995; 39(4):269-73. PubMed ID: 7651240
[TBL] [Abstract][Full Text] [Related]
12. Screening for T cell-eliciting proteins of Japanese encephalitis virus in a healthy JE-endemic human cohort using recombinant baculovirus-infected insect cell preparations.
Kumar P; Uchil PD; Sulochana P; Nirmala G; Chandrashekar R; Haridattatreya M; Satchidanandam V
Arch Virol; 2003 Aug; 148(8):1569-91. PubMed ID: 12898332
[TBL] [Abstract][Full Text] [Related]
13. A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen.
Hunt AR; Cropp CB; Chang GJ
J Virol Methods; 2001 Sep; 97(1-2):133-49. PubMed ID: 11483224
[TBL] [Abstract][Full Text] [Related]
14. Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults.
Saito Y; Moi ML; Takeshita N; Lim CK; Shiba H; Hosono K; Saijo M; Kurane I; Takasaki T
BMC Infect Dis; 2016 Oct; 16(1):578. PubMed ID: 27756212
[TBL] [Abstract][Full Text] [Related]
15. Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines--report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies.
Ferguson M; Johnes S; Li L; Heath A; Barrett A
Biologicals; 2008 Mar; 36(2):111-6. PubMed ID: 17892945
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated immune responses in healthy children with a history of subclinical infection with Japanese encephalitis virus: analysis of CD4+ and CD8+ T cell target specificities by intracellular delivery of viral proteins using the human immunodeficiency virus Tat protein transduction domain.
Kumar P; Krishna VD; Sulochana P; Nirmala G; Haridattatreya M; Satchidanandam V
J Gen Virol; 2004 Feb; 85(Pt 2):471-482. PubMed ID: 14769905
[TBL] [Abstract][Full Text] [Related]
17. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
[TBL] [Abstract][Full Text] [Related]
18. Japanese encephalitis vaccines: current vaccines and future prospects.
Monath TP
Curr Top Microbiol Immunol; 2002; 267():105-38. PubMed ID: 12082985
[TBL] [Abstract][Full Text] [Related]
19. Effect of current Japanese encephalitis vaccine on different strains of Japanese encephalitis virus.
Okuno Y; Okamoto Y; Yamada A; Baba K; Yabuuchi H
Vaccine; 1987 Jun; 5(2):128-32. PubMed ID: 3037813
[TBL] [Abstract][Full Text] [Related]
20. Enzyme-linked immunosorbent assay using recombinant antigens for serodiagnosis of Japanese encephalitis.
Konishi E; Mason PW; Shope RE
J Med Virol; 1996 Jan; 48(1):76-9. PubMed ID: 8825714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
